Carraway, Kermit L.

Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity.

Guy, P. M., Platko, J. V., Cantley, L. C., Cerione, R. A., & Carraway, K. L. (1994) · Proceedings of the National Academy of Sciences

HER2/EGFR in Cancer ResearchProtein Kinase Regulation and GTPase Signaling

Cited by 698

Met receptor contributes to trastuzumab resistance of Her2-overexpressing breast cancer cells

Shattuck, D. L., Miller, J. K., Carraway, K. L., & Sweeney, C. (2008) · Cancer Research

HER2/EGFR in Cancer ResearchLung Cancer Treatments and Mutations

Cited by 473

The erbB3 gene product is a receptor for heregulin.

Carraway, K. L., Sliwkowski, M. X., Akita, R., Platko, J. V., Guy, P. M., Nuijens, A., Diamonti, A. J., Vandlen, R. L., Cantley, L. C., & Cerione, R. A. (1994) · Journal of Biological Chemistry

HER2/EGFR in Cancer ResearchBiotin and Related Studies

Cited by 362

Neuregulin-Induced ErbB3 Downregulation Is Mediated by a Protein Stability Cascade Involving the E3 Ubiquitin Ligase Nrdp1

Cao, Z., Wu, X., Yen, L., Sweeney, C., & Carraway, K. L. (2007) · Molecular and Cellular Biology

HER2/EGFR in Cancer ResearchUbiquitin and proteasome pathways

Cited by 119

Combined defects in epithelial and immunoregulatory factors exacerbate the pathogenesis of inflammation: mucin 2-interleukin 10-deficient mice

van der Sluis, M., Bouma, J., Vincent, A., Velcich, A., Carraway, K. L., Büller, H. A., Einerhand, A. W. C., van Goudoever, J. B., Van Seuningen, I., & Renes, I. B. (2008) · Laboratory Investigation

Inflammatory Bowel DiseaseIL-33, ST2, and ILC Pathways

Cited by 44

Regulation of the T-box transcription factor Tbx3 by the tumour suppressor microRNA-206 in breast cancer

Amir, S., Simion, C., Umeh-Garcia, M., Krig, S., Moss, T., Carraway, K. L., & Sweeney, C. (2016) · British Journal of Cancer

MicroRNA in disease regulationCancer-related molecular mechanisms research

Cited by 38